SOUTH SAN FRANCISCO, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that it will present at the investor conferences listed below.
- Citi's 10th Annual Biotech Conference at 11:00 a.m. EDT, Thursday, September 10, 2015 at the Mandarin Oriental New York in New York City, New York.
- Morgan Stanley Global Healthcare Conference at 10:30 a.m. EDT, Wednesday, September 16, 2015 at the Grand Hyatt New York in New York City, New York.
The live audio webcast of the Company presentation from the Morgan Stanley Global Healthcare Conference will be accessible from the Company's investor relations website at http://investors.atarabio.com/events.cfm. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archive of the webcast will be available for at least 30 days following the presentations.
About Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with debilitating diseases. Atara Bio's programs include molecularly targeted product candidates and T-cell product candidates. Molecularly targeted product candidates include PINTA 745, STM 434 and ATA 842, members of the TGF-beta family of proteins that target myostatin and activin, and have demonstrated the potential to have therapeutic benefit in a number of clinical indications. T-cell product candidates include EBV-CTL, CMV-CTL and WT1-CTL.
CONTACT: INVESTOR CONTACT: Tina Gullotta, Atara Biotherapeutics, Inc. 650-741-1613 firstname.lastname@example.orgSource:Atara Biotherapeutics